|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cholera | |||||
| 2 | More general conditions related to this trial | ||||
| Bacterial Infections | |||||
| Gram-Negative Bacterial Infections | |||||
| Vibrio Infections | |||||
| 3 | Interventions listed in this trial | ||||
| Azithromycin | |||||
| 4 | More general drug interventions related to this trial | ||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| International Centre for Diarrhoeal Disease Research, Bangladesh | |||||
| Pfizer | |||||
| Tufts Medical Center | |||||